Primary |
Product Used For Unknown Indication |
43.2% |
Pain |
13.5% |
Rheumatoid Arthritis |
13.5% |
Analgesic Therapy |
8.1% |
Antiviral Prophylaxis |
5.4% |
Back Pain |
5.4% |
Anxiety |
2.7% |
Depression |
2.7% |
Intentional Drug Misuse |
2.7% |
Osteoarthritis |
2.7% |
|
Epilepsy |
12.5% |
Toxicity To Various Agents |
12.5% |
Overdose |
8.3% |
Tachycardia |
8.3% |
Haematoma |
4.2% |
Hallucination |
4.2% |
Loss Of Consciousness |
4.2% |
Oedema Peripheral |
4.2% |
Pain |
4.2% |
Psychomotor Hyperactivity |
4.2% |
Rhinorrhoea |
4.2% |
Sleep Disorder |
4.2% |
Suicidal Ideation |
4.2% |
Tremor |
4.2% |
Urinary Tract Infection |
4.2% |
Ventricular Failure |
4.2% |
Vomiting |
4.2% |
Wrong Technique In Drug Usage Process |
4.2% |
|
Secondary |
Product Used For Unknown Indication |
72.0% |
Drug Use For Unknown Indication |
5.7% |
Rheumatoid Arthritis |
2.9% |
Completed Suicide |
2.3% |
Pain |
2.3% |
Fibromyalgia |
1.7% |
Hiv Infection |
1.7% |
Ill-defined Disorder |
1.7% |
Neuropathy Peripheral |
1.7% |
Arthritis |
1.1% |
Prostatomegaly |
1.1% |
Tibia Fracture |
1.1% |
Anxiety |
0.6% |
Depression |
0.6% |
Essential Hypertension |
0.6% |
Hypertonic Bladder |
0.6% |
Intentional Overdose |
0.6% |
Migraine |
0.6% |
Mineral Supplementation |
0.6% |
Non-small Cell Lung Cancer |
0.6% |
|
Toxicity To Various Agents |
41.8% |
Completed Suicide |
9.1% |
Drug Abuse |
9.1% |
Overdose |
5.5% |
Intentional Drug Misuse |
3.6% |
Poisoning |
3.6% |
Tachycardia |
3.6% |
Deep Vein Thrombosis |
1.8% |
Drug Intolerance |
1.8% |
Drug Level Above Therapeutic |
1.8% |
Exposure Via Ingestion |
1.8% |
Hyponatraemia |
1.8% |
Intentional Overdose |
1.8% |
Mechanical Complication Of Implant |
1.8% |
Metastases To Central Nervous System |
1.8% |
Pain |
1.8% |
Palpitations |
1.8% |
Rash Pustular |
1.8% |
Serotonin Syndrome |
1.8% |
Suicidal Ideation |
1.8% |
|
Concomitant |
Product Used For Unknown Indication |
18.5% |
Depression |
8.7% |
Multiple Sclerosis |
8.7% |
Plasma Cell Myeloma |
8.7% |
Hepatitis C |
5.4% |
Colorectal Cancer Metastatic |
4.9% |
Immunodeficiency Common Variable |
4.9% |
Osteoporosis |
4.3% |
Drug Use For Unknown Indication |
3.8% |
Type 2 Diabetes Mellitus |
3.3% |
Arthralgia |
3.3% |
Chronic Lymphocytic Leukaemia |
3.3% |
Hypertension |
3.3% |
Nephrogenic Anaemia |
3.3% |
Type 2 Diabetes Mellitus |
3.3% |
Actinic Keratosis |
2.7% |
Back Pain |
2.7% |
Neuralgia |
2.7% |
Drug Use For Unknown Indication |
2.2% |
Chronic Myeloid Leukaemia |
2.2% |
|
Vomiting |
13.8% |
Weight Increased |
8.8% |
Tremor |
7.5% |
Weight Decreased |
6.3% |
White Blood Cell Count Decreased |
6.3% |
Myocardial Infarction |
5.0% |
Pain In Extremity |
5.0% |
Psychotic Disorder |
5.0% |
Rash |
5.0% |
Renal Impairment |
5.0% |
Stress Fracture |
5.0% |
Headache |
3.8% |
Transaminases Increased |
3.8% |
Treatment Failure |
3.8% |
Vision Blurred |
3.8% |
Anaemia |
2.5% |
Aphasia |
2.5% |
Drug Ineffective |
2.5% |
Duodenal Ulcer Haemorrhage |
2.5% |
Erythema |
2.5% |
|